Outcomes of the Medacta shoulder implant system in people with shoulder joint problems
Follows people who received the Medacta shoulder implant for shoulder arthritis or fracture.
Plain-language title generated from the registry record
Registry title: Clinical and Radiological Outcomes of Medacta Shoulder System FR
Key facts
- Where
- Annecy, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a shoulder problem who are having a Medacta shoulder implant. It follows how they do after surgery.
- Age
- Older than 18 years
- Sex
- All sexes can join.
- Disease stage
- One of these shoulder conditions: primary or secondary osteoarthritis, rotator cuff tear arthropathy or an insufficient rotator cuff, an acute fracture (less than 21 days old), rheumatoid or inflammatory arthritis, avascular necrosis, another condition after an injury, or a revision of a shoulder arthroplasty.
Main reasons for not taking part
- Malignant disease at the time of surgery
- Proven or suspected infection at the time of surgery
- Functional deficits other than the shoulder problem at the time of surgery
- Known incompatibility or allergy to the implant materials at the time of surgery
Read by machine on 12 November 2026.
Where in France
- Clinique Générale AnnecyAnnecy, FranceContact: Bruno Toussaint, DrTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Medacta International SA
- Trial code
- NCT05926622
- Record updated
- 29 September 2025
- Original description
This is a post-marketing surveillance on Medacta Shoulder SystemRead full original descriptionShow less
Clinical and Radiological Outcomes of Medacta Shoulder System
This is a post-marketing surveillance on Medacta Shoulder System
Inclusion: Patients older than 18 years; Patient with one of the following diagnosis:; Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty.
Exclusion: Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery); Patients with malignant diseases (at the time of surgery); Patients with proven or suspect infections (at the time of surgery); Patients with known incompatibility or allergy to products materials (at the time of surgery).